Clinical Trials Directory

Trials / Completed

CompletedNCT02399059

Effect of Peritoneal Lavage With Clindamycin-Gentamicin Solution & Oncologic Outcome

Effect of Peritoneal Lavage With Clindamycin-Gentamicin Solution During Elective Colorectal Cancer Surgery on the Oncologic Outcome

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
106 (actual)
Sponsor
Hospital General Universitario Elche · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Antibiotic lavage reduces bacterial contamination and decreases SSI infection rate. SSI leads to an immunocompromised situation, leaving unattended the neoplasm. It has been described that SSI may result in a worse oncologic outcome.

Detailed description

Antibiotics combined with lavage have demonstrated a reduction in the bacterial contamination and decreases SSI infection rate. SSI leads to an immunocompromised situation, as immunologic defense is focused on controlling the septic focus, leaving unattended the neoplasm. It has been described that SSI may result in a worse oncologic outcome. The aim of this study is to evaluate prospectively the effect of peritoneal lavage with clindamycin and gentamicin on the oncologic outcome of colorectal tumours.

Conditions

Interventions

TypeNameDescription
PROCEDUREAntibiotic lavagePeritoneal irrigation with gentamycin-clindamycin solution
PROCEDURENormal saline lavagePeritoneal irrigation with normal saline

Timeline

Start date
2011-01-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2015-03-26
Last updated
2015-03-26

Source: ClinicalTrials.gov record NCT02399059. Inclusion in this directory is not an endorsement.